搜索筛选:
搜索耗时0.0836秒,为你在为你在102,285,761篇论文里面共找到 20 篇相符的论文内容
类      型:
[期刊论文] 作者:Wang Zhijian,Xu Qingde,Wang Ga, 来源:中国针灸 年份:1995
ClinicalResearehonBodyAcupunctureandMassageTherapyforTreatmentofApoplexy¥WangZhijian;XuQingde;WangGang;WangBiao(HospitalofGao.........
[期刊论文] 作者:Ju Liu,Zhijian Xu,Xiaofeng Bi,, 来源:中国医学科学杂志:英文版 年份:2021
Objective To characterize Chinese families in which both parents and at least one child are diagnosed with malignant diseases and provide reference for cancer s...
[会议论文] 作者:Lanbo Di,Zhijian Xu,Xiuling Zhang, 来源:等离子体催化与能源材料应用研讨会(ISPCEM2012) 年份:2012
In recent years,many researchers adopted noble metals such as Pt,Pd,Au and Ag to modify TiO2 surface to enhance its photocatalytic activity under visible light....
[期刊论文] 作者:Zhijian Xu,Bin Qi,Lanbo Di,Xiu, 来源:能源化学:英文版 年份:2014
TiO2 decorated with partially crystallized Pd nanoparticles(Pd/TiO2-P) was successfully prepared by atmospheric-pressure dielectric barrier discharge cold plasma....
[期刊论文] 作者:Zhijian Xu,Bin Qi,Lanbo Di,Xiuling Zhang,, 来源:Journal of Energy Chemistry 年份:2014
TiO_2 decorated with partially crystallized Pd nanoparticles(Pd/TiO_2-P) was successfully prepared by atmospheric-pressure dielectric barrier discharge cold pla...
[期刊论文] 作者:Ju Liu,Zhijian Xu,Xiaofeng Bi,Ping Sun,Jiaqin Huang, 来源:中国医学科学杂志(英文版) 年份:2021
Objective To characterize Chinese families in which both parents and at least one child are diagnosed with malignant diseases and provide reference for cancer s...
[会议论文] 作者:ZONG Zhong,WANG Zhijian,XU Jingwe,宗中,王志坚,徐经纬, 来源:第19届全国计算机新科技与计算机教育学术大会 年份:2008
  网格安全在网格环境中有着重要的地位,它保证着整个网格的正常运作。理想状态是在网格环境的各个层次分别解决不同的安全需求。本文给出一种分层的网格安全架构设计方案,在......
[期刊论文] 作者:Bingqian Xie,Zhijian Xu,Guang Yang,Gege Chen,Bo Li,Liangning Hu,Wenqin Xiao, 来源:生物化学与生物物理学报(英文版) 年份:2016
Multiple myeloma (MM) is one of the most malignant cancers and is characterized by infiltration of bone marrow by plasma cells,secretion of monoclonal immunoglo...
[会议论文] 作者:Jumei Shi,Yuanyuan Kong,Bo Li,Shuaikang Chang,Zhijian Xu,Yi Tao,Weiliang Zhu, 来源:2019中国肿瘤学大会 年份:2019
[期刊论文] 作者:Yulong Shi,Xinben Zhang,Kaijie Mu,Cheng Peng,Zhengdan Zhu,Xiaoyu Wang,Yanqing Yang,Zhijian Xu,Weiliang, 来源:药学学报(英文版) 年份:2020
A highly effective medicine is urgently required to cure coronavirus disease 2019 (COVID-19).For the purpose,we developed a molecular docking based webserver,na...
[会议论文] 作者:Jumei Shi,Ting Zhang,Bo Li,Kang Lu,Qilin Feng,Hui Zhang,Zhijian Xu,Yi Tao,Weiliang Zhu, 来源:2019中国肿瘤学大会 年份:2019
Objective Multiple myeloma(MM) is a refractory malignant hematological malignancy,it is the second most common hematological malignancy in the world,after non-Hodgkins lymphoma.Many therapeutic strate...
[会议论文] 作者:Jumei Shi,Wang He,Zhijian Xu,Hui Zhang,Bo Li,Yi Tao,Yong Zhang,Zhangbo Chen,Weiliang Zhu, 来源:2019中国肿瘤学大会 年份:2019
[会议论文] 作者:Jumei Shi,Mengyu Xi,Bo Li,Wan He,Jun Hou,Zhijian Xu,Hui Zhang,Qilin Feng,Yi Tao,Rong Wei,Weiliang Zhu, 来源:2019中国肿瘤学大会 年份:2019
[期刊论文] 作者:Li,Xi Sun,Dandan Yu,Yongsheng Xie,Huiqun Wu,Shuaikang Chang,Yunfei Zhou,Houcai Wang,Xiucai Lan,Zhijian Xu, 来源:生物化学与生物物理学报(英文版) 年份:2018
DCZ3301, a novel aryl-guanidino compound, was previously found to have potent anti-tumor activity in myeloma and B-cell lymphoma. In the present study, we inves...
[会议论文] 作者:Li Feng,Huan Lu,Zhijian Xu,Zhuo Yang,Guoxin Du,Yu Zhang,Lijing Yu,Kaifeng Hu,Weiliang Zhu,Kaixian Chen, 来源:世界中医药学会联合会中药化学专业委员会第五届学术年会暨蒙医药论坛 年份:2016
Aims/hypothesis Pan-peroxisome proliferator-activated receptor (PPAR) agonists have long been sought as therapeutics against the metabolic syndrome, but current PPAR agonists show limited efficacy and...
[期刊论文] 作者:Mengyu Xi,Wan He,Bo Li,Jinfeng Zhou,Zhijian Xu,Huiqun Wu,Yong Zhang,Dongliang Song,Liangning Hu,Ye Lu, 来源:生物化学与生物物理学报(英文版) 年份:2020
Diffuse large B-cell lymphoma (DLBCL) is the most common category and disease entity of non-Hodgkin lymphoma.Osalmide and pterostilbene are natural products wit...
[期刊论文] 作者:Ke Hu,Bo Li,Ruye Ma,Hongfei Yi,Zhijian Xu,Yu Peng,Dandan Yu,Huiqun Wu,Taofang Cheng,Yumeng Lu,Yong Zhang, 来源:生物化学与生物物理学报(英文版) 年份:2021
Diffuse large B-cell lymphoma(DLBCL)is the most common type of non-Hodgkin lymphoma,char-acterized by high heterogeneity.The poor outcome of a portion of patien...
[期刊论文] 作者:Ting Zhang,Bo Li,Qilin Feng,Zhijian Xu,Cheng Huang,Huiqun Wu,Zhangbo Chen,Liangning Hu,Lu Gao,Peng Liu, 来源:生物化学与生物物理学报(英文版) 年份:2019
Multiple myeloma (MM) is a refractory malignant hematological malignancy,and many therapeutic strategies have been developed to cure patients with MM.DCZ0801 is...
[期刊论文] 作者:Dandan Yu,Yong Zhang,Gege Chen,Yongsheng Xie,Zhijian Xu,Shuaikang Chang,Liangning Hu,Bo Li,Wenxuan Bu, 来源:生物化学与生物物理学报(英文版) 年份:2018
Mantle cell lymphoma (MCL) is an aggressive and mostly incurable B-cell malignancy with frequent relapses after an initial response to standard chemotherapy.The...
[期刊论文] 作者:Liangning Hu,Huiqun Wu,Bo Li,Dongliang Song,Guang Yang,Gege Chen,Bingqian Xie,Zhijian Xu,Yong Zhang,Dandan, 来源:生物化学与生物物理学报(英文版) 年份:2017
Multiple myeloma (MM) is the second most frequent malignant hematological disease.Dihydrocelastrol (DHCE) is synthesized by hydrogenated celastrol,a treterpene...
相关搜索: